June 2026
We are pleased to share the first AIPD newsletter, Beyond Symptoms!. In this first issue, you can read about the project’s first General Assembly in Munich, the start of the doctoral candidates’ research and training journey, and their first impressions from joining the network. The newsletter also gives a preview of upcoming activities across the AIPD consortium.
May 21 to 22, 2026
At Bonn's Münsterplatz, the focus was on a disease that often begins subtly: Parkinson's. At the 15th Bonn Science Night, Fraunhofer SCAI demonstrated in the "City of Tents" how artificial intelligence can analyze early indicators of the disease—through changes in speech, movement, and biomarkers. What affected individuals may hardly notice can be a crucial signal for research.
Tent 5 highlighted the European doctoral network AIPD. The abbreviation stands for "Artificial Intelligence in Parkinson's Disease." The project collects and analyzes digital indicators from speech, movement, and biomarkers. The goal: to detect Parkinson's earlier, assess disease progression more accurately, and tailor treatments more precisely to individual patients.
The topic's impact was evident in the reaction of one visitor. After the presentation, she said: "I am very impressed. Please continue this important research."
The AIPD coordinator was also present at the booth: Prof. Dr. Holger Fröhlich heads the "Biomedical AI & Data Science" department at Fraunhofer SCAI. AIPD brings together industry and academia, supporting 14 PhD researchers at 15 institutions across eight countries.
October 29 to 31, 2025
The AIPD PhD Conference, held over three days immediately after the GA, provided an intensive program of scientific and transferable skills training aimed at the doctoral candidates. The conference was designed to foster interdisciplinary exchange, deepen scientific knowledge, and further support the integration and professional development of all DCs.
October 27 to 28, 2025
The AIPD General Assembly (GA) took place at GE Healthcare, associate partner in AIPD, from October 27 to 28, 2025, in Munich. It marked a major milestone in the project, acting not only as a coordinating meeting for all partners and stakeholders but also as the official kick-off for the newly recruited doctoral candidates (DCs). The event brought together representatives from all beneficiary institutions and associated partners, including a member of the Scientific Advisory Board (SAB), with the express purpose of strengthening collaboration, ensuring transparency, and setting the tone for future research and training activities.
Artificial Intelligence in Parkinson’s Disease